10898 Federal Register / Vol. 66, No. 34 / Tuesday, February 20, 2001 / Notices

Dated: February 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4088 Filed 2–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Amended Notice

of Meeting

Notice is hereby given of a change in

the meeting of the Mental Retardation

Research Subcommittee, March 12,

2001, 8 a.m. to March 14, 2001, 5 p.m.,

Embassy Suites, Chevy Chase Pavilion,

4300 Military Rd., Wisconsin at Western

Ave., Washington, DC 20015 which was

published in the Federal Register on

January 31, 2001, 66 FR 8418.

The meeting will be held on March

12–13, 2001. The meeting is closed to

the public.

Dated: February 9, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4091 Filed 2–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Library of Medicine; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Biomedical Library

Review Committee.

Date: March 7–8, 2001.

Closed: March 7, 2001, 8:30 a.m. to 11:30

a.m.

Agenda: To review and evaluate grant

applications.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Open: March 7, 2001, 11:30 a.m. to 2 p.m.

Agenda: ‘‘Permanent Access to Electronic

Information’’, Associate Director, Library

Operations, NLM.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Closed: March 7, 2001, 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Closed: March 8, 2001, 8:30 a.m. to 10:30

a.m.

Agenda: To review and evaluate grant

applications.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Open: March 8, 2001, 10:30 a.m. to 11 a.m.

Agenda: Remarks by the Director, NLM.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Closed: March 8, 2001, 11 a.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Library of Medicine, Board

Room Bldg 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Contact Person: Milton Corn, MD,

Associate Director, Office of Extramural

Programs, National Library of Medicine,

National Institutes of Health, One Rockledge

Centre, Suite 301, 6705 Rockledge Drive,

MSC 6075, Bethesda, MD 20892–6075, 301–

496–4621.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.879, Medical Library

Assistance, National Institutes of Health,

HHS)

Dated: February 9, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4089 Filed 2–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Method and Apparatus for

Constructing Tissue Microarrays

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: None.

SUMMARY: This is notice, in accordance

with 35 U.S.C 209(c)(1) and 37 CFR

404.7(a)(1)(i), that the National

Institutes of Health (NIH), Department

of Health and Human Services, is

contemplating the grant of an exclusive

license worldwide to practice the

inventions embodied in: (1) U.S. Patent

Application Serial No. 60/075,979 (PCT/

US99/04001) entitled ‘‘Tumor Tissue

Microarrays for Rapid Molecular

Profiling’’, provisionally filed February

24, 1998 and PCT filed February 24,

1999, and (2) U.S. Patent Application

Serial No. 60/170,461 (PCT/US00/

34043) entitled ‘‘Method and Apparatus

for Constructing Tissue Microarrays’’,

provisionally filed December 13, 1999

and PCT filed December 13, 2000, to

Beecher Instruments Company having a

place of business in Silver Spring,

Maryland. The United States of America

is an assignee to the patent rights of

these inventions.

The contemplated exclusive license

may be limited to the development of

instruments for the construction of

tissue microarrays for use for medical

research and clinical diagnostics.

DATES: Only written comments and/or

applications for a license which are

received by the NIH Office of

Technology Transfer on or before April

23, 2001 will be considered.

ADDRESSES: Requests for a copy of the

patent application, inquiries, comments

and other materials relating to the

contemplated license should be directed

to: Uri Reichman, Ph.D., Technology

Licensing Specialist, Office of

Technology Transfer, National Institutes

of Health, 6011 Executive Boulevard,

Suite 325, Rockville, MD 20852–3804;

Telephone: (301) 496–7056, ext. 240;

Facsimile: (301) 402–0220; E-mail:

reichmau@od.nih.gov. A signed

Confidential Disclosure Agreement will

be required to receive copies of the

patent application.

SUPPLEMENTARY INFORMATION: The

advent of the technology of Tissue

Microarrays (also called ‘‘Tissue Chips’’)

has made it possible to perform

simultaneous molecular profiling of

hundreds or even thousands of tissue

samples in a high-throughput fashion.

Tissue Microarrays include multiplicity

of sub-millimeter tissue specimens,

fixed and arranged on a single

microscope slide. The technology

provides means to generate hundreds of

identical copies of the slides. These

slides then can be used for specific

molecular analyses, such as DNA and

mRNA in situ hybridization and protein

immunostaining. The subject